Director Interviews
News Round ups
Small caps
News Round ups
Director Interviews
Market Report
Psychedelic medicines: Startups and innovators set the pace on trip to pharmaceutical mainstream
Taking the active ingredients of psychedelics and proving their effectiveness in the clinic...
The City broker left its forecasts unchanged but said there is room for upside depending on...
The City broker's forecasts are unchanged, while it has reiterated its 150p share price target
Oncimmune is a specialist in the field of immunodiagnostics
The diagnostics firm has been rocketing thanks to its efficient coronavirus tests, but it is...
Oncimmune Holdings PLC's (LON:ONC) Adam Hill tells Proactive the next 18 months are expected to create substantial revenues within the EarlyCDT lung cancer test business while the pipeline of contracts within the ImmunoINSIGHTS services business is building. In a trading update covering the...
Medical technology & services
Morning Report: FTSE 100 on the up as airline stocks surge higher
Get our market previews and stories before the main networks.
Not just the FTSE. Read about
opportunities from the whole
equities market.
Hear directors at first-hand
or meet them in person at our events.
Watch IPOs and access on the same terms as the institutions.
